A procedure for setting up high-throughput nanolitre crystallization experiments. II. Crystallization results

被引:33
作者
Brown, J
Walter, TS
Carter, L
Abrescia, NGA
Aricescu, AR
Batuwangala, TD
Bird, LE
Brown, N
Chamberlain, PP
Davis, SJ
Dubinina, E
Endicott, J
Fennelly, JA
Gilbert, RJC
Harkiolaki, M
Hon, WC
Kimberley, F
Love, CA
Mancini, EJ
Manso-Sancho, R
Nichols, CE
Robinson, RA
Sutton, GC
Schueller, N
Sleeman, MC
Stewart-Jones, GB
Vuong, M
Welburn, J
Zhang, Z
Stammers, DK
Owens, RJ
Jones, EY
Harlos, K
Stuart, DI
机构
[1] Oxford Prot Prod Facil, Oxford OX3 7BN, England
[2] Div Struct Biol, Oxford OX3 7BN, England
[3] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England
[4] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England
[5] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[6] Univ Oxford, Oxford Ctr Mol Sci, Dyson Perrins Lab, Oxford OX1 3QY, England
关键词
D O I
10.1107/S0021889803002012
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An initial tranche of results from day-to-day use of a robotic system for setting up 100 nl-scale vapour-diffusion sitting-drop protein crystallizations has been surveyed. The database of over 50 unrelated samples represents a snapshot of projects currently at the stage of crystallization trials in Oxford research groups and as such encompasses a broad range of proteins. The results indicate that the nanolitre-scale methodology consistently identifies more crystallization conditions than traditional hand-pipetting-style methods; however, in a number of cases successful scale-up is then problematic. Crystals grown in the initial 100 nl-scale drops have in the majority of cases allowed useful characterization of Xray diffraction, either in-house or at synchrotron beamlines. For a significant number of projects, full X-ray diffraction data sets have been collected to 3 Angstrom resolution or better (either in-house or at the synchrotron) from crystals grown at the 100 nl scale. To date, five structures have been determined by molecular replacement directly from such data and a further three from scale-up of conditions established at the nanolitre scale.
引用
收藏
页码:315 / 318
页数:4
相关论文
共 5 条
[1]   The prospects of protein nanocrystallography [J].
Bodenstaff, ER ;
Hoedemaeker, FJ ;
Kuil, ME ;
de Vrind, HPM ;
Abrahams, JP .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1901-1906
[2]   Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur [J].
Brown, J ;
Esnouf, RM ;
Jones, MA ;
Linnell, J ;
Harlos, K ;
Hassan, AB ;
Jones, EY .
EMBO JOURNAL, 2002, 21 (05) :1054-1062
[3]   The genesis of high-throughput structure-based drug discovery using protein crystallography [J].
Kuhn, P ;
Wilson, K ;
Patch, MG ;
Stevens, RC .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (05) :704-710
[4]   An approach to rapid protein crystallization using nanodroplets [J].
Santarsiero, BD ;
Yegian, DT ;
Lee, CC ;
Spraggon, G ;
Gu, J ;
Scheibe, D ;
Uber, DC ;
Cornell, EW ;
Nordmeyer, RA ;
Kolbe, WF ;
Jin, J ;
Jones, AL ;
Jaklevic, JM ;
Schultz, PG ;
Stevens, RC .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2002, 35 :278-281
[5]   A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation [J].
Walter, TS ;
Diprose, J ;
Brown, J ;
Pickford, M ;
Owens, RJ ;
Stuart, DI ;
Harlos, K .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2003, 36 :308-314